Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Wiman

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Oncogene|April 3, 2007
Reactivation of mutant p53: molecular mechanisms and therapeutic potentialG Selivanova, K G Wiman
Nature Medicine|August 1, 1997
An old acquaintance resurfaces in human mesotheliomaK G Wiman, G Klein
Advances in Cancer Research|January 1, 1995
p53: a cell cycle regulator activated by DNA damageG Selivanova, K G Wiman
Journal of Internal Medicine|April 5, 2017
Understanding cell cycle and cell death regulation provides novel weapons against human diseasesK G Wiman, B Zhivotovsky
Cell Death and Differentiation|May 30, 2015
TP53: an oncogene in disguiseT Soussi, K G Wiman
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Rearrangement and activation of the c-myc gene in avian and human B-cell lymphomasK G Wiman, W S Hayward
Current Opinion in Cell Biology|December 1, 1995
What is the restriction point?A Zetterberg, O Larsson, K G Wiman
Biochemical and Biophysical Research Communications|November 5, 1999
p53-induced apoptosis as a safeguard against cancerC Asker, K G Wiman, G Selivanova
Oncogene|May 22, 2001
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53M S Lindström, U Klangby, K G Wiman
Apoptosis : an International Journal on Programmed Cell Death|April 26, 2001
Inactivation of Myc-induced p53-dependent apoptosis in human tumorsM Henriksson, G Selivanova, M Lindström, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Oncogene|April 3, 2007
Reactivation of mutant p53: molecular mechanisms and therapeutic potentialG Selivanova, K G Wiman
Nature Medicine|August 1, 1997
An old acquaintance resurfaces in human mesotheliomaK G Wiman, G Klein
Advances in Cancer Research|January 1, 1995
p53: a cell cycle regulator activated by DNA damageG Selivanova, K G Wiman
Journal of Internal Medicine|April 5, 2017
Understanding cell cycle and cell death regulation provides novel weapons against human diseasesK G Wiman, B Zhivotovsky
Cell Death and Differentiation|May 30, 2015
TP53: an oncogene in disguiseT Soussi, K G Wiman
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Rearrangement and activation of the c-myc gene in avian and human B-cell lymphomasK G Wiman, W S Hayward
Current Opinion in Cell Biology|December 1, 1995
What is the restriction point?A Zetterberg, O Larsson, K G Wiman
Biochemical and Biophysical Research Communications|November 5, 1999
p53-induced apoptosis as a safeguard against cancerC Asker, K G Wiman, G Selivanova
Oncogene|May 22, 2001
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53M S Lindström, U Klangby, K G Wiman
Apoptosis : an International Journal on Programmed Cell Death|April 26, 2001
Inactivation of Myc-induced p53-dependent apoptosis in human tumorsM Henriksson, G Selivanova, M Lindström, et al.
Pageof 9